How do we optimise a patient’s statin therapy for the management of dyslipidaemia with minimal side effects?
RACGP for 2 (Category 2) points for GPsToggle information
This activity has been accredited for 2 (Category 2) points in the RACGP QI & CPD Program for the 2017–2019 triennium (activity number 99732).
ACRRM for 1 Core point for GPsToggle information
This activity has been accredited by ACRRM for 1 Core point in the ACRRM PD Program for the 2017–2019 triennium (ACRRM ID: 9538).
- Recognised for the Practice Incentives Program Quality Prescribing Incentive (PIP QPI)
Liam is a 62-year-old human resources manager with established hypertension. Recent blood test results show that Liam appears to have abnormal lipid levels. How will you interpret these findings? Does he need a statin? If so, how should statin therapy be optimised? And what would you do if Liam experienced muscle symptoms while on statin therapy?
Complete this online case study and receive instant feedback on your responses, compare your approach with your peers and read expert commentary provided by Professor of General Practice, Mark Harris, and editor of various editions of several prominent RACGP Guidelines.
On completion of this activity you should be able to:
- Interpret lipid levels in the context of absolute CV risk.
- Discuss the factors to consider when selecting and tailoring statin therapy.
- Use an adequate trial of statins to optimise lipid lowering before adding a second lipid-modifying agent.
- Identify the symptoms and risk factors of statin-associated muscle symptoms (SAMS) and apply a systematic approach to assessing and managing SAMS.